Recall: Brass Particles Found in Hospira's Sodium Chloride Injection

Hospira announced a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection, 1000mL, Flexible Container. This recall was due to one confirmed customer report where brass particulate was identified in the primary container appearing as several small gray/brown particles.

Sodium Chloride Injection is used as a source of water and electrolytes. The brass particulate was identified as containing copper, zinc, and lead. A solution containing brass particulate may result in occlusion of small blood vessels. Further, copper toxicity may result in hemolysis and liver toxicity, including hepatic necrosis which may be fatal.

The affected lot number is 25-037-JT (may be followed by a -01 or -90), NDC 0409-7983-09, with an expiration date of January 1, 2015.

For more information call (888) 480-2853 or visit www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm346011.htm.